INZY
Price
$0.93
Change
+$0.06 (+6.90%)
Updated
Apr 2 closing price
Capitalization
59.51M
40 days until earnings call
SLN
Price
$2.89
Change
+$0.47 (+19.42%)
Updated
Apr 2 closing price
Capitalization
120.42M
Ad is loading...

INZY vs SLN

Header iconINZY vs SLN Comparison
Open Charts INZY vs SLNBanner chart's image
Inozyme Pharma
Price$0.93
Change+$0.06 (+6.90%)
Volume$379.48K
Capitalization59.51M
Silence Therapeutics
Price$2.89
Change+$0.47 (+19.42%)
Volume$275.87K
Capitalization120.42M
INZY vs SLN Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. SLN commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and SLN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (INZY: $0.87 vs. SLN: $2.89)
Brand notoriety: INZY and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 77% vs. SLN: 104%
Market capitalization -- INZY: $59.51M vs. SLN: $120.42M
INZY [@Biotechnology] is valued at $59.51M. SLN’s [@Biotechnology] market capitalization is $120.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, both INZY and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while SLN’s TA Score has 4 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 2 bearish.
  • SLN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INZY is a better buy in the short-term than SLN.

Price Growth

INZY (@Biotechnology) experienced а -10.41% price change this week, while SLN (@Biotechnology) price change was -12.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

INZY is expected to report earnings on May 13, 2025.

SLN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($120M) has a higher market cap than INZY($59.5M). SLN YTD gains are higher at: -57.994 vs. INZY (-66.556). SLN has higher annual earnings (EBITDA): -48.99M vs. INZY (-95.72M). SLN has more cash in the bank: 147M vs. INZY (113M). SLN has less debt than INZY: SLN (117K) vs INZY (46.9M). SLN has higher revenues than INZY: SLN (43.3M) vs INZY (0).
INZYSLNINZY / SLN
Capitalization59.5M120M50%
EBITDA-95.72M-48.99M195%
Gain YTD-66.556-57.994115%
P/E RatioN/AN/A-
Revenue043.3M-
Total Cash113M147M77%
Total Debt46.9M117K40,085%
TECHNICAL ANALYSIS
Technical Analysis
INZYSLN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 27 days ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTJX16.960.10
+0.59%
Artisan International Small-Mid Investor
IBBFX13.730.03
+0.22%
Thrivent Dynamic Allocation S
HEOSX15.77N/A
N/A
Hartford Climate Opportunities R4
ARABX13.72N/A
N/A
Aristotle Small Cap Eq A
AWAYX20.45N/A
N/A
AB Wealth Appreciation Strategy Advisor

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+6.48%
IGMS - INZY
52%
Loosely correlated
+6.96%
MRSN - INZY
50%
Loosely correlated
+1.68%
CRNX - INZY
48%
Loosely correlated
+2.51%
DYN - INZY
48%
Loosely correlated
+7.37%
APGE - INZY
46%
Loosely correlated
+6.23%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+19.42%
CLLS - SLN
43%
Loosely correlated
-4.55%
CMVLF - SLN
38%
Loosely correlated
N/A
ABCZF - SLN
36%
Loosely correlated
N/A
RCKT - SLN
36%
Loosely correlated
+8.43%
NGNE - SLN
35%
Loosely correlated
+8.34%
More